Clinicopathological characteristics and molecular analysis of lymphocyte-rich hepatocellular carcinoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinicopathological characteristics and molecular analysis of lymphocyte-rich hepatocellular carcinoma
Authors
Keywords
-
Journal
HUMAN PATHOLOGY
Volume 141, Issue -, Pages 43-53
Publisher
Elsevier BV
Online
2023-09-23
DOI
10.1016/j.humpath.2023.09.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy
- (2022) Cleopatra Rutihinda et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Enrichment of CCR6 + CD8 + T cells and CCL20 in the lungs of mechanically ventilated patients with COVID‐19
- (2021) Anno Saris et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to immune evasion in hepatocellular carcinoma
- (2021) Masafumi Akasu et al. Scientific Reports
- The CCL20-CCR6 Axis in Cancer Progression
- (2020) Suguru Kadomoto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Lymphoepithelioma-like carcinoma in liver not associated with Epstein-Barr virus: a report of 3 cases and literature review
- (2020) Kai Zhang et al. Diagnostic Pathology
- β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma
- (2019) Marina Ruiz de Galarreta et al. Cancer Discovery
- Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling
- (2019) Dan Wang et al. Journal for ImmunoTherapy of Cancer
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Synchronous hepatocellular carcinoma and lymphoepithelioma-like carcinoma arising from 2 different sites of the liver
- (2018) En-Jie Shih et al. MEDICINE
- Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
- (2017) Julien Calderaro et al. JOURNAL OF HEPATOLOGY
- Lymphoepithelioma-like hepatocellular carcinoma
- (2017) Jun-Ke Wang et al. MEDICINE
- Histologic Assessment of Intratumoral Lymphoplasmacytic Infiltration Is Useful in Predicting Prognosis of Patients with Hepatocellular Carcinoma
- (2016) Akimasa Hayashi et al. PLoS One
- Lymphoepithelioma-like Hepatocellular Carcinoma
- (2015) Anthony W.H. Chan et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Characterization of Inflammatory (Lymphoepithelioma-like) Hepatocellular Carcinoma: A Study of 8 Cases
- (2014) Kalyani R. Patel et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Hepatocellular Carcinoma with Immature T-Cell (T-lymphoblastic) Proliferation
- (2010) Shin Eun et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+T cells in lymphocyte-rich gastric carcinoma
- (2008) H Ohtani et al. JOURNAL OF PATHOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started